medline.ch Respirationstrakt Neoplasie

	Phase II Multicenter Clinical Trial of Intraoperative Molecular Imaging with Abenacianine During Lung Cancer Surgery. Ann Surg Oncol Herrera LJ, Wright GM, Kim JY, Reisenauer JS, Rice DC, Singhal S. PMID: 42502096 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial. Ann Surg Oncol Folkert IW, Mehran R, Sun R, Morris VK, Overman MJ, Kee B, Antonoff MB, Tzeng CW, Dasari A, Cao HT, Parseghian CM, Vilar E, Willis J, Newhook TE, Hofstetter W, Kopetz SE, Vauthey JN, Chun YS. PMID: 42502090 [PubMed - as supplied by publisher]
	Streamlining the Frequency, Conduct, and Location of Assessments in Registrational Lung Cancer Clinical Trials for Supplemental Applications: Recommendations of a LUNGevity Foundation Multistakeholder Working Group. Clin Lung Cancer Guidry JT, Carbone DP, Johnson ML, McKelvey BA, James L, Krug LM, Pietanza MC, Ferris AE. PMID: 42501613 [PubMed - as supplied by publisher]
	An Observational Population Level Study of Neoadjuvant Chemoimmunotherapy for Resectable Non-Small-Cell Lung Cancer. Clin Lung Cancer Goutam S, Gibson AJW, Dean ML, Miller AR, de Oliveira BR, Navani V. PMID: 42501612 [PubMed - as supplied by publisher]
	Small molecule allosteric modulators of mutant EGFR for non-small cell lung cancer therapy: An insight into design strategies and structure activity relationships. Eur J Med Chem Dash S, Ghosh M, Shehensha SK, Meduri R, Sahoo BM, Dhar AK, Dinda SC. PMID: 42501451 [PubMed - as supplied by publisher]
	Nanotechnology-enabled precision targeting of lung cancer stem cells: Recent developments and therapeutic implications. Stem Cell Rev Rep Zhang Y, Fan J, Ye Y, Li C, Lang MF. PMID: 42501212 [PubMed - as supplied by publisher]
	Pulmonary Tumor Thrombotic Microangiopathy Diagnosed by Right Heart Catheterization in a Patient With Breast Cancer: A Case Report. Cureus Tajima S, Nakata Y, Sanda K, Koshimo Y, Shigematsu M. PMID: 42500795 [PubMed]
	Re-evaluating the Role of Whole Brain Radiotherapy for Brain Metastases From Non-small Cell Lung Cancer in the Immunotherapy Era: A Retrospective Cohort Study. Cureus Forster P. PMID: 42500752 [PubMed]
	Delafloxacin suppresses DEPDC1 expression and induces G2/M arrest in non-small cell lung cancer cells: A drug repurposing study. Smart Mol Ali N, Shafiq F, Iftikhar M, Zafar MS, Shoaib M. PMID: 42500733 [PubMed - as supplied by publisher]
	Enhanced through-bond energy transfer-based bioorthogonal probe enables catalytic-amplified and sensitive detection of microRNA-21 for clinical lung cancer diagnosis. Smart Mol Li Y, Han F, Huang H, Zhou D, Long S, Sun W, Du J, Fan J, Ning J, Peng C, Peng X. PMID: 42500706 [PubMed - as supplied by publisher]
	Cancer Drug Development in Never-Smoker Lung Cancer: Targeted and Immune-Based Therapeutic Strategies. Oncol Res Cojocaru C, Costuleanu M, Petri, Cojocaru R, Vasîncu D, Cojocaru E. PMID: 42500583 [PubMed - indexed for MEDLINE]
	GPX4 Defines an Immune-Cold Phenotype and Poor Prognosis in Resected Lung Adenocarcinoma. Oncol Res Wang G, Liu Z, Zhou T, Yang B, Chen J, Chen J, Huang K, Xu Y, Tang Q, Yin X, Xiao G, Zhang S. PMID: 42500575 [PubMed - indexed for MEDLINE]
	ANLN: A New Hub in Glutamine Metabolism of Lung Adenocarcinoma by scRNA-Seq and Machine Learning. Oncol Res Ma Y, Zhang Z, Pan H, Jiang H, Guo L, Guo F. PMID: 42500572 [PubMed - indexed for MEDLINE]
	Effect of high-intensity interval training on clinical outcomes in lung cancer patients undergoing surgery: a meta-analysis based on randomized controlled trials. Front Med (Lausanne) Li D, Chen H, Zuo Q, Lv F, Shen K, Sun M. PMID: 42500527 [PubMed]
	Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non-small cell lung cancer and brain metastases receiving whole-brain radiotherapy. Precis Radiat Oncol Ni J, Lu Y, Xu H, Xu X, Zhao M, Xue Y, Li G, Duan Y. PMID: 42500423 [PubMed - as supplied by publisher]
	Real-world evidence of baseline soluble CD25 as a prognostic biomarker and indicator of differential EGFR-TKI benefit in stage IV lung adenocarcinoma. Front Oncol Guo H, Liu L, Lindberg V, Xue Y, Baak JPA. PMID: 42500294 [PubMed]
	Cost-effectiveness analysis of first-line gefitinib plus anlotinib treatment for patients with stage IIIB-IV EGFR-mutated NSCLC in China. Front Public Health Chen P, Jiang Y, Chen Y, Luo S, Wu C, Tang Q, Zhang D, Wang Y, Ma J. PMID: 42500005 [PubMed - indexed for MEDLINE]
	Effect of programmed cell death protein-1 inhibitor combined with platinum-containing dual-agent chemotherapy regimen on gut microbiota in Lewis lung cancer model mice. Front Microbiol Dai L, Kong FL. PMID: 42499661 [PubMed]
	Efficacy and prognostic factors of first-line bevacizumab plus chemotherapy in elderly patients with advanced driver gene-negative lung adenocarcinoma: A retrospective study. Medicine (Baltimore) Li S, Wang S, Cao R. PMID: 42499069 [PubMed - indexed for MEDLINE]
	Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial. J Immunother Cancer Gonzalez-Cao M, Sisteré-Oró M, Moran T, Reguart N, Cabezon R, Aguilar Hernández A, Roman R, Molina-Vila MA, Birgin K, Domenjo-Vila E, Piqué G, Lozano M, Charry P, Reyes R, Moya I, Cirera L, Esparre C, Drozdowskyj A, Martínez Pérez E, Rosell R, Juan M, Meyerhans A, Benitez-Ribas D. PMID: 42498486 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 161787

Seite 1 von 8090



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung